Magnetic resonance-guided focused ultrasound surgery (MRgFUS), which is the least invasive surgical method for treating uterine myomas, is not ideal for type 3 high-intensity myomas.
Magnetic resonance-guided focused ultrasound surgery (MRgFUS), which is the least invasive surgical method for treating uterine myomas, is not ideal for type 3 high-intensity myomas. That's the case because the treated area ratio immediately after the procedure is small compared with that for type 1 and 2 myomas, and the subsequent volume change is unfavorable, according to the results of a prospective study from Japan.
The authors of the study followed 48 myomas in 35 women with MR images for 6 months after MRgFUS and followed 23 myomas in 17 women for 12 months after MRgFUS.
They found that while some type 1 and 2 myomas had reduced perfused volume 6 months after the procedure, all type 3 myomas showed increased perfused volume at 6 months post-MRgFUS, indicating, as has been previously suggested, that type 3 myoma cells naturally resist focused ultrasound energy and heating effects.
Funaki K, Fukunishi H, Funaki T, et al. Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction. J Minim Invasive Gynecol. 2007;14:616-621.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Study finds pregnancy risks higher with ART in kidney transplant recipients
July 11th 2025Women with kidney transplants who conceive through assisted reproductive technology face increased risks of complications such as hypertension, preterm birth, and cesarean delivery, according to new research.
Read More